文献速递衰弱、肌少症与跌倒老年慢病共病管理

前列腺癌幸存者跌倒与衰弱:雄激素剥夺治疗当前、既往与从未使用者的比较

Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy.
PubMed 文献 · J Am Geriatr Soc · 2017-03-06

横断面研究纳入280例前列腺癌幸存者(平均年龄72±8岁),比较当前、既往和从未使用雄激素剥夺治疗(ADT)者的跌倒与衰弱患病率及关联。当前或既往ADT使用者跌倒风险、反复跌倒、跌倒相关损伤及衰弱(含肥胖衰弱表型)患病率均显著高于从未使用者,传统和肥胖衰弱表型均显著增加跌倒及反复跌倒风险。

要点

  • 当前或既往ADT使用者跌倒风险是从未使用者的两倍以上。
  • ADT使用者衰弱及肥胖衰弱+衰弱前期患病率显著更高。
  • 传统和肥胖衰弱表型均显著增加跌倒及反复跌倒风险。

核心结论

  • 当前或既往ADT暴露与前列腺癌幸存者更高的跌倒和衰弱风险相关。

研究设计与样本

  • 横断面研究,通过邮件和电子问卷纳入280例前列腺癌幸存者,平均年龄72±8岁。

主要发现

  • 传统衰弱表型增加过去一年跌倒风险(OR=2.15,95%CI=1.18-3.94),肥胖衰弱表型OR=2.97(95%CI=1.62-5.58);反复跌倒风险传统OR=3.10(95%CI=1.48-6.5),肥胖OR=3.99(95%CI=1.79-8.89)。

临床怎么用

  • 应对前列腺癌幸存者进行跌倒预防咨询,尤其关注当前或既往ADT使用者。
  • 应考虑评估并干预衰弱,以降低跌倒风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the prevalence of and association between falls and frailty of prostate cancer survivors (PCSs) who were current, past or never users of androgen deprivation therapy (ADT). DESIGN: Cross-sectional. SETTING: Mail and electronic survey. PARTICIPANTS: PCSs (N = 280; mean age 72 ± 8). MEASUREMENTS: Cancer history, falls, and frailty status (robust, prefrail, frail) using traditionally defined and obese phenotypes. RESULTS: Current (37%) or past (34%) ADT users were more than twice as likely to have fallen in the previous year as never users (15%) (P = .002). ADT users had twice as many recurrent falls (P < .001) and more fall-related injuries than unexposed men (P = .01). Current (43%) or past (40%) ADT users were more likely to be classified as prefrail or frail than never users (15%) (P < .001), and the prevalence of combined obese frailty + prefrailty was even greater in current (59%) or past (62%) ADT users than never users (25%) (P < .001). Traditional and obese frailty significantly increased the likelihood of reporting falls in the previous year (odds ratio (OR) = 2.15, 95% CI = 1.18-3.94 and OR = 2.97, 95% CI = 1.62-5.58, respectively) and was also associated with greater risk of recurrent falls (OR = 3.10, 95% CI = 1.48-6.5 and OR = 3.99, 95% CI = 1.79-8.89, respectively). CONCLUSIONS: Current and past exposure to ADT is linked to higher risk of falls and frailty than no treatment. PCSs should be appropriately counseled on fall prevention strategies, and approaches to reduce frailty should be considered.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Winters-Stone KM, Moe E, Graff JN, et al. Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy. J Am Geriatr Soc. 2017. PMID: 28263373. doi:10.1111/jgs.14795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。